Protagenic Therapeutics, Inc.
PTIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,343 | $13,509 | $1,428 | $44,591 |
| - Cash | $2,722 | $4,096 | $873 | $1,838 |
| + Debt | $3,156 | $4,013 | $0 | $0 |
| Enterprise Value | $6,777 | $13,426 | $555 | $42,753 |
| Revenue | $0 | $0 | $0 | -$25 |
| % Growth | – | – | 100% | – |
| Gross Profit | $0 | -$13 | -$13 | -$50 |
| % Margin | – | – | – | 200% |
| EBITDA | -$1,114 | -$4,806 | -$1,436 | -$1,541 |
| % Margin | – | – | – | 6,128.9% |
| Net Income | -$869 | -$5,058 | -$1,440 | -$1,554 |
| % Margin | – | – | – | 6,180.6% |
| EPS Diluted | -0.47 | -1.37 | -2.75 | -0.24 |
| % Growth | 65.7% | 50.2% | -1,045.8% | – |
| Operating Cash Flow | -$1,495 | -$1,167 | -$1,068 | -$820 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1,495 | -$1,167 | -$1,068 | -$820 |